Vinvest SRL
Vinvest reported total assets of €2.43m at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).
The score of Vinvest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +22 % Total assets +23 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vinvest's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Vinvest's financial analysis
- Solvency43.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vinvest
Vinvest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.022.086
- VAT number
- BE0451022086
- Peppol
- Registered · 0208:0451022086 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 1993
- Registered office
- 2650 Edegem
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Vinvest (SRL) has been based in Edegem since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 76,341 € and equity of €1.05m; its revenue is not published. Its solvency stands at 43.3%, below the median of its sector (44.2%).
Companies similar to Vinvest
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Peeters Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €2.43m
- Extrapharm HUY Retail sale of pharmaceutical products Huy · balance sheet €2.43m
- Holsbeek Brecht - Sint -Lenaerts Retail sale of pharmaceutical products Brecht · balance sheet €2.44m
- DE BIE T. Retail sale of pharmaceutical products Affligem · balance sheet €2.45m
- De Witte - De Sutter Retail sale of pharmaceutical products Dendermonde · balance sheet €2.45m
- Abfab Retail sale of pharmaceutical products Anderlecht · balance sheet €2.46m
- Vidafar Retail sale of pharmaceutical products Deinze · balance sheet €2.40m
- Tamiphar Retail sale of pharmaceutical products Lasne · balance sheet €2.46m
Frequently asked questions about Vinvest
What is the revenue of Vinvest?
Vinvest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vinvest?
In Belgium, the VAT number is the company number prefixed with BE: BE0451022086 for Vinvest, if the company is VAT-registered. Its company number (CBE) is 0451.022.086.
Where is the registered office of Vinvest?
According to the CBE register, the registered office of Vinvest is in 2650 Edegem.
What is the equity of Vinvest?
At the close of the 2025 financial year, the equity of Vinvest amounts to 1,051,818 €, a solvency of 43.3% of total assets.
Who manages Vinvest?
The register lists 3 active mandates at Vinvest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vinvest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →